The Effect of Intradermal Local Anesthetic Injection in FBSS (Failed Back Surgery Syndrome) (FBSS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04268602

Recruitment Status : Not yet recruiting

First Posted : February 13, 2020

Last Update Posted : July 30, 2020

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

Duygu Geler Külcü, Haydarpasa Numune Training and Research Hospital

Study Description

Brief Summary:

Failed Back Surgery Syndrome is described as chronic pain in the low back and/or legs after a spinal procedure. It is estimated that %10 - 40 of the patients who had spinal surgery will have Failed Back Surgery Syndrome. The aim of this study is to research whether intradermal injection of the local anesthetic on the operation scar area and the area in which pain referred to in patients with Failed Back Surgery Syndrome has effects on pain and functionality or not.

Condition or disease	Intervention/treatment	Phase
Failed Back Surgery Syndrome Pain, Chronic	Other: local anesthetic injection	Not Applicable

Show detailed description

Detailed Description:

The prevalence of low back pain is around 60% - 80% and its the 5th most common disease to seek medical help. 80% of patients who have an acute onset of low back pain whether treated or not relieved on symptoms, while unfortunately 10% of patients' low back pain will worsen end eventually progress to chronic low back pain. With the increase on the number of different techniques on spinal surgery, and an increase in the number of patients who had risk factors undergone spinal surgery caused an increase in the number of patients who had new complaints after surgery. The term Failed Back Surgery Syndrome describes new complaints or not enough ease on the complaints of a patient who had spinal surgery. Due to the variation of the criteria of assessment, it is noted that around 10% -40% of the patients who had spinal surgery will have Failed Back Surgery Syndrome.

Failed Back Surgery Syndrome is commonly described as pain in low back and/or legs with difficulty in daily activities. Pain might be radicular or localized to the low back, it might be mechanic or neuropathic in nature.

Some of the pathologies that cause Failed Back Surgery Syndrome are loss of height on the disc, arthrosis, spinal stenosis caused by the hypertrophy of the facet joints, recurrent disc herniation, arachnoiditis, central stenosis, epidural fibrosis, instability, pseudoarthrosis, and discitis.

Rehabilitation is one of the vital parts of the treatment of Failed Back Surgery Syndrome. After a detailed patient history and a complete physical examination, clinicians should create a rehabilitation program that aims improvements on pain, functionality, quality of life and activities of daily living and is tailored for the patient. It is shown that patients who undergo rehabilitation programs had improvements in physical functionality, posture, and difficulties with walking. Other conservative treatments include cognitive behavioral therapy and noninvasive injection techniques.

Literature shows that multifidus muscle is damaged and atrophied in the patients who had spinal surgery. Also, there is a correlation between functional impairment and atrophy. Usually, the muscles that control flexion and extension of the low back are weak in patients who have low back pain. Extensor muscles, especially the erector spinae muscle group are the posterior stabilisers of the vertebral colon. Loss of endurance and weakness of these muscles and low back pain have a correlation and strengthening these muscles will result in an improvement in low back pain.

Injections of local anesthetics on chronic pain syndromes are being used successfully for a long time. There are some examples of successful interventions on pelvic pain, myofascial pain syndrome and nonspecific chronic low back pain in the literature. While surgery is the first line of treatment in cases where the cause is the compromise of the neural structures or spinal instability, the pain will increase with recurrent surgery in other causes. Ligaments of the intervertebral disc complex which are innervated by the nociceptive neurons, facet joints, and paravertebral muscles are thought to be the reason for pain in Failed Back Surgery Syndrome. In a systemic review that took place in 2015; the superiority of injections done with saline, a mixture of steroids and local anesthetics and steroids alone for facet joints and epidural injection procedure was investigated. Investigators demonstrated that injection with local anesthetics alone was effective in treatment. Another systemic review in 2019 showed that injection of local anesthetics was effective and was superior to botulinum toxin A in the treatment of myofascial pain.

Intradermal injection of a drug is related to longer pharmacological effects compared to intramuscular and subcutaneous injections. Lidocaine antinociceptive, analgesic, anti-bacterial, anti-fungal, anti-viral, wound healing, releasing of endogen opioid effects were demonstrated. In the light of all the information above, the investigators wanted to research whether intradermal injection of the local anesthetic in patients with Failed Back Surgery Syndrome has effects on pain and functionality or not.

Study Design

Layout table for study information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	80 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Intervention Model Description:	randomized controlled study
Masking:	Single (Outcomes Assessor)
Primary Purpose:	Other
Official Title:	The Effect of Intradermal Local Anesthetic Injection on Pain and Functionality in Failed Back Surgery Syndrome
Estimated Study Start Date :	September 1, 2020
Estimated Primary Completion Date :	March 1, 2021
Estimated Study Completion Date :	July 1, 2021

Arms and Interventions

Arm	Intervention/treatment
Experimental: Intervention Group intradermal 1% lidocain injection 4 cc+ exercise and transcutaneous electrical nerve stimulation	Other: local anesthetic injection 1% lidocaine Other Name: exercise and transcutaneous electrical nerve stimulation
No Intervention: Control Group exercise and transcutaneous electrical nerve stimulation

Outcome Measures

Primary Outcome Measures :

Change in Visual Analog Pain Scale scores [ Time Frame: baseline, immediately after the intervention, 1 month ]
Visual analog scale for measurement of pain. Minimum-maximum scores are 0-10. Higher scores mean worse outcome
Change in OSWESTRY Disability Index scores [ Time Frame: baseline, immediately after the intervention, 1 month ]
Low Back Pain Disability Questionnaire. Minimum-maximum scores are 0-100. Higher scores mean worse outcome

Secondary Outcome Measures :

Change in Hospital anxiety and depression scores [ Time Frame: baseline, immediately after the intervention, 1 month ]
anxiety and depression evaluation. Minimum-maximum scores are 0-21. Higher scores mean worse outcome
change in modified schober test measurement [ Time Frame: baseline, immediately after the intervention, 1 month ]
measurement to asses the mobility of lumbar vertebrae (cm)
change in Lateral hand to ground test measurement [ Time Frame: baseline, immediately after the intervention, 1 month ]
measurement to asses the mobility of lumbar vertebrae (cm)

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Having been diagnosed with failed back surgery syndrome
18-75 years of age
visual analogue pain score> 4 to be

Exclusion Criteria:

Mental problems
Having a disease affecting the central nervous system or peripheral nervous system
Fixation operation to the lumbar region
Physical therapy in the lumbar region within the last 3 months
Injection from the lumbar region in the last 3 months
Lidocaine allergy
Needle phobia.
Wound, infection, allergy, burn-type lesions in the area to be injected
Malignity history

Contacts and Locations

No Contacts or Locations Provided

More Information

Layout table for additonal information

Responsible Party:	Duygu Geler Külcü, Clinical Professor Dr, Head of Physical Medicine and Rehabilitation Department, Haydarpasa Numune Training and Research Hospital
ClinicalTrials.gov Identifier:	NCT04268602
Other Study ID Numbers:	HNEAH-KAEK2019/23-757
First Posted:	February 13, 2020 Key Record Dates
Last Update Posted:	July 30, 2020
Last Verified:	July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:	No

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No
Product Manufactured in and Exported from the U.S.:	No

Keywords provided by Duygu Geler Külcü, Haydarpasa Numune Training and Research Hospital:


FBSS Failed Back Surgery Syndrome Chronic Pain local anesthetic Intradermal Injection

Additional relevant MeSH terms:

Layout table for MeSH terms

Syndrome Chronic Pain Failed Back Surgery Syndrome Disease Pathologic Processes Pain Neurologic Manifestations Postoperative Complications	Back Pain Anesthetics Anesthetics, Local Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents

To Top